NEWBIOTICS
NewBiotics transforms drug resistances into therapeutic advantages. It focuses on the discovery and development of drug molecules that leverage the cycle of drug resistance in both cancer and infectious diseases. NewBiotics is a U.S.-based company that was founded in 1997 and the company was acquired by Celmed Biosciences on June 7, 2004.
NEWBIOTICS
Industry:
Health Care Medical Therapeutics
Founded:
1997-09-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.newbiotics.com
Total Employee:
11+
Status:
Active
Total Funding:
21.87 M USD
Technology used in webpage:
SPF Amazon AWS Global Accelerator
Investors List
Inglewood Ventures
Inglewood Ventures investment in Series E - NewBiotics
GeneChem
GeneChem investment in Series E - NewBiotics
Life Sciences Partners
Life Sciences Partners investment in Series E - NewBiotics
BioVeda Capital
BioVeda Capital investment in Series C - NewBiotics
Cheng Xin Technology Development Corp
Cheng Xin Technology Development Corp investment in Series C - NewBiotics
Life Sciences Partners
Life Sciences Partners investment in Series C - NewBiotics
FAT Capital
FAT Capital investment in Series C - NewBiotics
Inglewood Ventures
Inglewood Ventures investment in Series C - NewBiotics
GeneChem
GeneChem investment in Series C - NewBiotics
Life Sciences Partners
Life Sciences Partners investment in Venture Round - NewBiotics
Official Site Inspections
http://www.newbiotics.com
- Host name: ec2-3-64-163-50.eu-central-1.compute.amazonaws.com
- IP address: 3.64.163.50
- Location: Seattle United States
- Latitude: 47.6348
- Longitude: -122.3451
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98109
